about
Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studiesThe latest on the effect of prior exercise on postprandial lipaemiaChlorinated persistent organic pollutants, obesity, and type 2 diabetesAtherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetesLow dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control studyPerspectives on vascular biology and diabetes.Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosis.Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.Association of egg consumption and calcified atherosclerotic plaque in the coronary arteries: the NHLBI Family Heart Study.Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study.Evaluation of the immune response to pneumococcal capsular polysaccharides.The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin.Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet.Use of Metformin in Patients with Kidney and Cardiovascular Diseases.LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B.The Associations of Serum Lipids with Vitamin D Status.Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.Physical activity as a mediator of the impact of chronic conditions on quality of life in older adults.Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications.Pathobiology of obstructive sleep apnea-related dyslipidemia: focus on the liver.Differential Effects of Continuous and Interval Exercise Training on the Atherogenic Index of Plasma in the Non-Obese Young Male.Blood-Based Indicators of Insulin Resistance and Metabolic Syndrome in Bottlenose Dolphins (Tursiops truncatus)Global Metabolic Profiling of Plasma Shows that Three-Year Mild-Caloric Restriction Lessens an Age-Related Increase in Sphingomyelin and Reduces L-leucine and L-phenylalanine in Overweight and Obese Subjects.Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.The Triglyceride to HDL Ratio and Its Relationship to Insulin Resistance in Pre- and Postpubertal Children: Observation from the Wausau SCHOOL ProjectA Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis.Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.Predictors of insulin sensitivity in Type 2 diabetes mellitus.Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.Insulin sensitivity modifies the relationship between thyroid function and lipid profile in euthyroid type 1 diabetic patients.Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men.Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism.The Effect of Bariatric Surgery Type on Lipid Profile: An Age, Sex, Body Mass Index and Excess Weight Loss Matched Study.Lifestyle intervention leading to moderate weight loss normalizes postprandial triacylglycerolemia despite persisting obesity.Kalpaamruthaa ameliorates mitochondrial and metabolic alterations in diabetes mellitus induced cardiovascular damage.Analytical Methods for Metformin Estimation.
P2860
Q26823037-55A9E9E6-FF3A-42CE-A969-1D3E6AB11847Q27024852-8ADA9E52-7ACA-4A37-A15A-3ED77D1A366BQ33569410-CC275158-DE91-47E6-9A78-EF927FB41506Q33776194-F44E08E3-4848-4399-9586-108A85937DB0Q33846858-070A0B02-673E-4B44-86FA-08840CB2D48BQ34057028-08693AA0-E930-4C88-A632-6EEE646535ABQ34113740-F1A56B0C-FAF1-4223-A517-6DE20E993FC4Q34161037-307A9BD3-1926-4B67-8A9F-376612C3DC9BQ34289026-85A99D48-E468-4EED-BBC7-A8C63210DE94Q34511337-9F810962-0F03-4EB5-AC9C-12ABBF543582Q35022579-0EC69E2A-8D45-409D-85F4-D459313C4E7FQ35123350-CF2C7729-0D86-4D7D-A832-B734EAB288CCQ35167055-ADD4A3B8-EF9C-4BB2-A594-53774A8919D4Q35637978-F32C311A-286A-43E6-8301-1775FF667455Q35684097-F8F8878C-9A19-45DC-A7CB-4038EC85E1CFQ35688570-F4FE6669-A1DC-49A7-8EE8-AF6CFF98C89AQ35844561-B0B197C8-8229-427C-9455-C32057D76E3BQ35849884-4AAB9203-1738-4DE3-8E82-8D4EA26811BFQ36170979-F6A510B3-BFC6-4D01-9936-F2C8313178F7Q36323175-7E99962C-78C9-4494-A6C1-D8DE77BC0CBDQ36465126-5884BC70-080F-4160-B348-B5D516C67BD9Q36521113-C8A60502-E00E-44A3-BF95-FA3A856E45E8Q36546481-2E862243-B842-41FD-A8D8-BE26D2AB99BCQ36721647-3890FEC6-B519-4171-A305-D54CB5E462EEQ37221640-3C244739-D752-4598-9D44-BC6D69F4A5C7Q37544169-D31E3716-6B09-4264-932D-E2C31197C7EBQ38388185-E1D7470B-342F-4C50-85FF-1AEF34FA6AE0Q42080965-894C584B-5632-4807-BA2C-E08626A4C2FFQ42370958-DA98C99E-DCB9-4D68-BAC3-7B7C7F5E16EEQ43601277-C57BA1BB-EDBF-4652-8130-6E7C8A4DC8B6Q43903083-C2435741-63BF-421B-9C7A-B4228F0EE3C0Q44051661-1331862B-F3DB-4C28-9089-B7C76E9B1BBFQ44393961-1B22DEB1-71E0-4FC4-85CB-91E682C07E15Q44739166-E5F5D73B-2533-4C30-997E-1306D0B588B1Q45150101-B780277A-4F8D-4191-865D-80E9CBA25330Q45330225-2390BF75-DA24-4360-9FBF-227D40B27A09Q47372148-338AD837-7EF1-4E7E-AC6B-2DFDAD04D582Q47411581-0B3DB2DB-4161-4CFF-BD77-E1DA18E16F59Q47669076-55757841-0C00-42B4-BBC1-640D4356E92FQ48139438-61F636CF-35FD-4841-8CD5-02D5AF8F6ECD
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Insulin resistance and lipid metabolism.
@ast
Insulin resistance and lipid metabolism.
@en
type
label
Insulin resistance and lipid metabolism.
@ast
Insulin resistance and lipid metabolism.
@en
prefLabel
Insulin resistance and lipid metabolism.
@ast
Insulin resistance and lipid metabolism.
@en
P1476
Insulin resistance and lipid metabolism.
@en
P2093
P304
P356
10.1016/S0002-9149(99)00355-0
P407
P577
1999-07-01T00:00:00Z